Advanced Enzyme

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE837H01020
NSEID: ADVENZYMES
BSEID: 540025
View on NSE | View on BSE

INR

278.40

-11.6 (-4.0%)

BSENSE

Mar 13

BSE+NSE Vol: 2.4 lacs

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

SMS Pharma.

Senores Pharma.

RPG LifeScience.

Guj. Themis Bio.

Unichem Labs.

Advanced Enzyme

Aarti Drugs

Gufic BioScience

Dishman Carbogen

Orchid Pharma

SPARC

Why is Advanced Enzyme Technologies Ltd ?

Poor long term growth as Operating profit has grown by an annual rate -2.90% of over the last 5 years

Flat results in Dec 25

PBT LESS OI(Q) At Rs 38.57 cr has Fallen at -14.91%
CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 76.42 cr
PAT(Q) At Rs 34.17 cr has Fallen at -9.3%

With ROE of 9.9, it has a Very Expensive valuation with a 2.1 Price to Book Value

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 3.44%, its profits have fallen by -0.3%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Advanced Enzyme for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Advanced Enzyme

3.44%

0.09

36.63%

Sensex

1.0%

0.08

12.13%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

8.18%

EBIT Growth (5y)

-2.90%

EBIT to Interest (avg)

65.88

Debt to EBITDA (avg)

0.19

Net Debt to Equity (avg)

-0.38

Sales to Capital Employed (avg)

0.46

Tax Ratio

28.27%

Dividend Payout Ratio

10.24%

Pledged Shares

Institutional Holding

31.37%

ROCE (avg)

20.60%

ROE (avg)

10.67%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.10

EV to EBIT

14.84

EV to EBITDA

12.04

EV to Capital Employed

2.79

EV to Sales

3.59

PEG Ratio

Dividend Yield

1.87%

ROCE (Latest)

19.55%

ROE (Latest)

9.93%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

NO KEY POSITIVE TRIGGERS

-5What is not working for the Company

PBT LESS OI(Q)

At Rs 38.57 cr has Fallen at -14.91%

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 76.42 cr

PAT(Q)

At Rs 34.17 cr has Fallen at -9.3%

Loading Valuation Snapshot...

Here's what is not working for Advanced Enzyme

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 38.57 cr has Fallen at -14.91%

Year on Year (YoY)

MOJO Watch

Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs 34.17 cr has Fallen at -9.3%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is negative

PAT (Rs Cr)

Cash and Cash Equivalents - Half Yearly

Lowest at Rs 76.42 cr

in the last six half yearly periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents